Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD38 (clone C1G34I7J). We employs the Retrovirus (T7-mScarlet-c-Jun-HindIII) vector components and the SynExpress system of the Exons Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD38
Clone
C1G34I7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mScarlet
Promoter
T7
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
Knock-in
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.92
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.